Soru

Zorluk: OrtaBreast Disorders

A 56-year-old menopausal patient is evaluated in the clinic after noticing a hard, painless nodule in her left breast. On clinical examination, there is a 1.5-cm, immobile, firm mass located in the upper outer quadrant. No skin dimpling, nipple discharge, or axillary lymphadenopathy is present. Arrange the following steps in the most appropriate chronological sequence for the complete evaluation and standard management of this patient's condition.

  1. 1Bilateral diagnostic mammography and targeted ultrasound
  2. 2Image-guided core needle biopsy of the mass
  3. 3Biomarker evaluation (ER, PR, and HER2 status) of the tissue specimen
  4. 4Breast-conserving surgery with sentinel lymph node biopsy
  5. 5Adjuvant whole-breast radiation therapy

Cevap

The correct sequence begins with diagnostic imaging, followed by tissue diagnosis, biomarker testing, surgical resection, and finally adjuvant radiation.
The standard diagnostic and therapeutic algorithm for a palpable breast mass in a woman age 30 or older begins with bilateral diagnostic mammography and targeted ultrasound. If imaging confirms a highly suspicious lesion, an image-guided core needle biopsy is performed. Once invasive carcinoma is diagnosed, the tissue must undergo biomarker evaluation (ER, PR, HER2) to inform treatment options. The patient then undergoes primary locoregional surgical treatment, typically breast-conserving surgery with sentinel lymph node biopsy for an early-stage 1.5-cm tumor. Finally, adjuvant whole-breast radiation therapy is administered, which is standard of care following breast-conserving surgery to reduce local recurrence.

Adım Adım Çözüm

1
Select the initial imaging modality.
Bilateral diagnostic mammography and targeted ultrasound.
Patients 30 years of age and older presenting with a new palpable breast mass require mammography and ultrasound for comprehensive evaluation.
2
Obtain tissue for histologic diagnosis.
Image-guided core needle biopsy.
Suspicious solid masses on imaging require core needle biopsy rather than fine-needle aspiration to evaluate tissue architecture and invasiveness.
3
Assess tumor characteristics to guide systemic therapy.
Biomarker evaluation (ER, PR, HER2) of the biopsy specimen.
Receptor status must be known to formulate an appropriate multidisciplinary treatment plan.
4
Perform definitive surgical management.
Breast-conserving surgery with sentinel lymph node biopsy.
This approach provides survival outcomes equivalent to mastectomy with less morbidity for early-stage localized disease.
5
Determine necessary postoperative local therapy.
Adjuvant whole-breast radiation therapy.
Radiation is a required component of breast-conserving therapy to ensure adequate local control.

Anahtar Kavram

The sequential diagnostic workup and standard management of a palpable breast mass in women aged 30 and older.
Bu soruyu puanla